Cardiac Implants Devices Market to grow at CAGR of 12.5% over 2015-2020
According to a report published by IndustryArc, the global cardiac implantable devices market recorded revenue of USD 21.4 billion in 2014 and will grow at a CAGR of 12.5% over 2015-2020. The major factors contributing to the growth of business include a rise in the number of patients suffering from cardiovascular diseases such as coronary artery diseases (CAD), cardiac arrhythmia and aortic aneurysms and origin of innovative products such as leadless pacemakers and subcutaneous defibrillators (S-ICDs). America holds the major share of 60% followed by Europe with 22%. The report divides the market into pacemakers, ICDs, CRTs, coronary stents, heart valves and TAVI valves based on devices and into myocardial ischemia, arrhythmias and acute myocardial infarction based on conditions. The major players of this market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Abbott Vascular and Edwards Life-sciences.
Read the full article at GlobeNewswire